HES5 and glioblastoma: We investigated if the mutually exclusive expression of a Notch pathway ligand (JAG1) and target (HES5) consistent with lateral inhibition could be found in primary glioblastoma by examining in greater detail three previously reported, double stained GBM specimens [19].